BeStock  
Stocks › Biotechnology › SANA

Sana Biotechnology SANA

US equityMarket cap rank #3398Biotechnology
$2.70 −$0.02 (-0.74%)
Market open · Oct 8, 10:00 am ET · After hours $2.80 +2.94%
Open$2.72
Prev close$2.72
Day range$2.66 – $2.73
Volume345.5K
Market cap$808.27M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership79.1%-3.34 pts vs. prior quarter
Institutions holding241-1 vs. prior quarter
Insider trades (recent)37 buys / 10 sellsNet buying
Short interest13.82% of floatDays to cover 12.2 · as of 15 Sep 2026
Short-sale volume share27.4%5-day average of daily volume

Short-sale volume as % of daily volume

16%26%36%46%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$5.54M (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

−$5.7MSuper+$205.0KBig+$913.4KMid+$877.9KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 46.5% of shares outstanding.

Largest holders

  • Arch Venture Partners, L.P.15.32%
  • FMR10.99%
  • Flagship Pioneering, Inc8.35%
  • RA Capital Management, L.P.6.26%
  • BlackRock5.57%
  • State Street Global Advisors3.74%
  • Canada Pension Plan Investment Board3.41%
  • Vanguard Capital Management, LLC3.21%

By investor type

  • VC/PE Fund34.19%
  • Mutual Fund31.68%
  • Individual/Insider6.30%
  • Public Company4.79%
  • Hedge Fund4.07%
  • Government Pension Fund3.62%
  • Private Company0.54%
  • Insurance Company0.12%

Reported short interest has fallen from 13.91% to 13.82% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Putnam LLC Mutual Fund 2026/Q3 +130,655 0.0%
Putnam Fiduciary Trust Company Private Company 2026/Q3 +124,492 0.0%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +347,599 0.1%
Riverbridge Partners, LLC Mutual Fund 2026/Q3 +152,878 0.1%
RA Capital Management, L.P. VC/PE Fund 2026/Q3 +18,750,000 6.3%
Bank of America Corporation Public Company 2026/Q3 +2,794,012 1.9%
BlackRock Mutual Fund 2026/Q3 +2,434,998 5.6%
Marshall Wace LLP Hedge Fund 2026/Q3 +2,266,979 1.0%
The Toronto-Dominion Bank Public Company 2026/Q3 +1,972,381 0.7%
Jacobs Levy Equity Management Inc Mutual Fund 2026/Q3 +1,868,718 0.6%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +1,114,485 3.2%
State Street Global Advisors Mutual Fund 2026/Q3 +665,048 3.7%
Point72 Asset Management, L.P. Hedge Fund 2026/Q3 +595,091 0.2%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +495,986 1.6%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q3 +457,097 0.5%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
26 Aug 2026 Dhavalkumar Patel Chief Scientific Officer Derivative Exercise and Sale -41,158 $4.11 183,352
25 Aug 2026 Dhavalkumar Patel Chief Scientific Officer Derivative Exercise and Retained +83,842 – 183,352
5 Jul 2026 Hans Edgar Bishop Independent Chairperson Other Acquisition +6,297 – 5,854,800
3 Jun 2026 Robert Taylor Nelsen Independent Director Other Derivative Acquisition +90,000 $2.96 90,000
3 Jun 2026 Yuhmin Yang Independent Director Other Derivative Acquisition +90,000 $2.96 90,000
3 Jun 2026 Michelle Seitz Independent Director Other Derivative Acquisition +90,000 $2.96 90,000
3 Jun 2026 Richard Mulligan Executive Vice Chairman & Head of Innovation Research Other Derivative Acquisition +90,000 $2.96 90,000
3 Jun 2026 Hans Edgar Bishop Independent Chairperson Other Derivative Acquisition +90,000 $2.96 90,000
3 Jun 2026 Joshua Bilenker Independent Director Other Derivative Acquisition +90,000 $2.96 90,000
3 Jun 2026 Alise Reicin Independent Director Other Derivative Acquisition +90,000 $2.96 90,000
3 Jun 2026 Robert Rosiello Director Other Derivative Acquisition +90,000 $2.96 90,000
5 Apr 2026 Hans Edgar Bishop Independent Chairperson Other Acquisition +7,763 – 5,848,503
23 Mar 2026 Dhavalkumar Patel Chief Scientific Officer Initial Statement of Beneficial +0 – 1,396,250
8 Mar 2026 Steven Harr Chief Executive Officer Derivative Exercise and Sale -24,345 $3.13 8,960,751
8 Mar 2026 Susan Wyrick Acting CFO, Treasurer, Principal Accounting Officer and Senior VP of Finance & Accounting Derivative Exercise and Sale -4,387 $3.13 196,196
6 Mar 2026 Steven Harr Chief Executive Officer Derivative Exercise and Retained +67,321 – 8,960,751
5 Mar 2026 Susan Wyrick Acting CFO, Treasurer, Principal Accounting Officer and Senior VP of Finance & Accounting Derivative Exercise and Retained +9,279 – 196,196
4 Mar 2026 Steven Harr Chief Executive Officer Other Derivative Acquisition +200,000 – 200,000
4 Mar 2026 Steven Harr Chief Executive Officer Other Derivative Acquisition +900,000 $3.41 900,000
4 Mar 2026 Susan Wyrick Acting CFO, Treasurer, Principal Accounting Officer and Senior VP of Finance & Accounting Other Derivative Acquisition +45,833 – 45,833

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 41,374,811 13.8% 12.2
31 Aug 2026 41,563,334 13.9% 16.1
14 Aug 2026 42,568,975 14.2% 18.0
31 Jul 2026 42,148,007 15.1% 16.3
15 Jul 2026 39,736,380 14.3% 13.2
30 Jun 2026 38,698,572 13.9% 9.1

Discussion

No comments yet — be the first to weigh in on SANA.

Leave a comment

Scroll to Top